Tianjin Zhongxin Pharmaceutical Group Corp Ltd represents values of innovation, integrity, and quality in the pharmaceutical industry. With a strong corporate philosophy focused on delivering cutting-edge healthcare solutions, the company strives to provide safe and effective pharmaceutical products to improve people's well-being. Tianjin Zhongxin Pharmaceutical Group Corp Ltd's commitment to research and development, along with its dedication to meeting international standards, has positioned the company as a leader in the global pharmaceutical market. Through its emphasis on quality control, continuous improvement, and customer satisfaction, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the delivery of reliable and trustworthy healthcare solutions.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is primarily present in China.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has achieved several significant milestones. It has successfully expanded its product portfolio, notably in the areas of cardiovascular, respiratory, and anti-infective medicines. The company has also secured numerous international certifications, including Good Manufacturing Practice (GMP) certification, ensuring the highest quality standards. Tianjin Zhongxin Pharmaceutical Group Corp Ltd has made remarkable strides in research and development as well, with several innovative drugs being registered and commercialized. Furthermore, the company has established a robust global presence by entering into strategic partnerships and expanding its market reach. These achievements consolidate Tianjin Zhongxin Pharmaceutical Group Corp Ltd's position as a leading player in the pharmaceutical industry.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, a leading pharmaceutical company, has a rich history and background. Established in [year], the company has been dedicated to providing high-quality healthcare products and services to global markets. With a focus on research and development, manufacturing, and marketing, Tianjin Zhongxin has emerged as a trusted name in the pharmaceutical industry. Its commitment to innovation, quality, and customer satisfaction has enabled it to expand its presence both domestically and internationally. Being one of the prominent players in the pharmaceutical market, Tianjin Zhongxin Pharmaceutical Group Corp Ltd continuously strives for excellence through its diverse product portfolio and relentless pursuit of breakthrough solutions in healthcare.

The main competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the market include other leading pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm Group Co., Ltd., Fosun Pharma, and Jiangsu Hengrui Medicine Co., Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd primarily operates in the pharmaceutical industry.

The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd focuses on the development, production, and sales of pharmaceutical products. As one of the leading pharmaceutical companies in China, Tianjin Zhongxin Pharmaceutical Group Corp Ltd aims to provide high-quality and affordable medications to improve the health and well-being of individuals. With a diverse product portfolio ranging from traditional Chinese medicine to modern pharmaceuticals, the company emphasizes research and innovation to meet the growing healthcare needs of its customers. By adhering to strict quality standards and maintaining a strong distribution network, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the availability and accessibility of its products nationwide.

مُعامل القيمة السوقية إلى الأرباح لـ Tianjin Pharmaceutical Da Ren Tang Group Corp هو ٢٠٫٧٩.

مُعامِل القيمة إلى المبيعات Tianjin Pharmaceutical Da Ren Tang Group Corp هو ٢٫٧٥.

نقاط جودة AlleAktien لـ Tianjin Pharmaceutical Da Ren Tang Group Corp هي 7/10.

المتوقعة Tianjin Pharmaceutical Da Ren Tang Group Corp الإيرادات هي ٩٫١٢ مليارات CNY.

صافي الربح المتوقعة Tianjin Pharmaceutical Da Ren Tang Group Corp هو ١٫٢١ مليارات CNY.

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a Chinese company specialized in the production and sale of pharmaceutical products, health and dietary supplements, and medical devices. Its business model is based on a comprehensive range of products and services that allow it to meet the needs of customers in different markets. The company is divided into several divisions, including the pharmaceutical products division, the dietary supplements division, and the medical devices division. Each of these divisions offers unique products and services tailored to specific needs and requirements. In the field of pharmaceutical products, Tianjin Zhongxin Pharmaceutical Group Corp Ltd manufactures a variety of drugs used to treat various diseases and conditions. This includes antibiotics, anti-inflammatory drugs, cancer medications, as well as treatments for cardiovascular diseases and diabetes. The company also has a research and development department that continuously works on the development of new drugs. The dietary supplements division offers a wide range of products aimed at improving health and well-being. These include vitamins, minerals, enzymes, and herbal extracts. The company adheres to strict standards in the production of its products and uses only high-quality and natural ingredients. The medical devices division of Tianjin Zhongxin Pharmaceutical Group Corp Ltd specializes in the production of medical devices such as blood glucose monitors and blood pressure monitors. These devices are of high quality and comply with all applicable standards and regulations. The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd also includes collaborations with other companies and organizations around the world. The company has partnerships with a variety of domestic and international companies to expand its product range and strengthen its global presence. Overall, the business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is focused on the development, production, and sale of high-quality pharmaceutical products, dietary supplements, and medical devices. Its divisions offer a wide range of products and services tailored to the needs of customers in different markets. Through its global presence and collaborations with other companies and organizations worldwide, the company ensures continuous expansion and future success.

يوزع Tianjin Pharmaceutical Da Ren Tang Group Corp أرباحًا قدرها ٠٫٥٠ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Tianjin Pharmaceutical Da Ren Tang Group Corp في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـTianjin Pharmaceutical Da Ren Tang Group Corp هو CNE000001808.

الرمز المُختصر لـ Tianjin Pharmaceutical Da Ren Tang Group Corp هو 600329.SS.

خلال آخر 12 شهراً، دفعت Tianjin Pharmaceutical Da Ren Tang Group Corp توزيعات أرباح بقيمة ١٫١٢ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٣٫٤٣ %. ومن المتوقع أن تدفع Tianjin Pharmaceutical Da Ren Tang Group Corp خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ١٫٢١ CNY.

نسبة توزيعات الأرباح الحالية لـ Tianjin Pharmaceutical Da Ren Tang Group Corp هي ٣٫٤٣ %.

Tianjin Pharmaceutical Da Ren Tang Group Corp يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يوليو, يوليو, يوليو, يوليو.

Tianjin Pharmaceutical Da Ren Tang Group Corp دفعت توزيعات الأرباح كل عام خلال الـ16 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ١٫٢١ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٣٫٧٠ %.

Tianjin Pharmaceutical Da Ren Tang Group Corp يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٫١٢ CNY من Tianjin Pharmaceutical Da Ren Tang Group Corp المُعلن عنها في ٦‏/٦‏/٢٠٢٣، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٦‏/٦‏/٢٠٢٣.

تم توزيع آخر دفعة من الأرباح بتاريخ ٦‏/٦‏/٢٠٢٣.

في العام 2023، وزعت Tianjin Pharmaceutical Da Ren Tang Group Corp ٠٫٥ CNY كأرباح أسهم.

يتم توزيع أرباح Tianjin Pharmaceutical Da Ren Tang Group Corp بالعملة CNY.